Back to trial details

Intake questionnaire

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Applying to University of Chicago Medical Center · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Advanced or Metastatic Solid Tumors?
3. Are you able to travel to Chicago for study visits?